Related Experiment Video

Updated: May 17, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Heme and HO-1 Inhibition of HCV, HBV, and HIV

Warren N Schmidt1, M Meleah Mathahs, Zhaowen Zhu

  • 1Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, University of Iowa Iowa City, IA, USA ; Department of Internal Medicine, Roy G. and Lucille A. Carver College of Medicine, University of Iowa Iowa City, IA, USA.

Frontiers in Pharmacology
|October 13, 2012
PubMed

Insights

Heme compounds show broad-spectrum antiviral activity against Hepatitis C virus, HIV, and Hepatitis B virus by inhibiting viral replication. These findings support developing heme-based therapies for chronic viral infections.

Area of Science:

  • Virology
  • Biochemistry
  • Immunology

Background:

  • Chronic viral infections like Hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Hepatitis B virus (HBV) pose significant global health challenges.
  • These viruses cause substantial morbidity and mortality worldwide, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To critically evaluate and summarize studies on the antiviral properties of heme oxygenase-1 and related compounds.
  • To discuss recent findings on the mechanisms and viral targets of these unique antiviral agents.

Main Methods:

  • Review of seminal and recent in vitro studies.
  • Analysis of biochemical pathways involving heme oxygenase system products.
  • Characterization of viral replication inhibition.

Main Results:

  • Heme oxygenase-1, its oxidative products, and related heme compounds demonstrate in vitro inhibition of HCV, HIV, and HBV replication.
  • These compounds exhibit similar target sites across these diverse viral pathogens.
  • Antiviral mechanisms and specific viral targets have been elucidated in recent research.

Conclusions:

  • Heme and related tetrapyrroles display broad-spectrum antiviral activity against major chronic viral infections.
  • The conserved antiviral mechanisms suggest potential for developing versatile therapeutic agents.
  • Further development of heme-based compounds is warranted for treating single or multiple viral infections.

Keywords:
HBVHCVHIVHemebiliverdinmetalloporphyrinsproteasesviruses

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...